Corrigendum re: "TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer" [Eur Urol 2016;70:709-13]

Eur Urol. 2017 Aug;72(2):e49. doi: 10.1016/j.eururo.2017.02.027. Epub 2017 Mar 1.

¹ Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
² Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
³ Medical Oncology Department, Hospital Plató, Barcelona, Spain.
⁴ Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
⁵ Department of Pathology, Hospital Clónic, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
⁶ Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
⁷ Translational Genomics and Targeted Therapeutics in Solid Tumours Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Electronic address: [email protected].

No abstract available

Publication types